Clinical trial

First in Human Study of SIM0610 in Solid Tumors

NCT07348211

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-19

PhasePHASE1

Study timeline

Study start (actual)2026-01-19Date precision: day

Registry last updated2026-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumoursunresolved

Non-Small Cell Lung Cancerunresolved

Colorectal Cancerunresolved

Head and Neck Squamous Cell Carcinomaunresolved

Hepatocellular Carcinomaunresolved

Interventions

SIM0610 for InjectionDRUG

SIM0610 for InjectionDRUG

Sponsors & collaborators

Jiangsu Simcere Pharmaceutical Co., Ltd.lead sponsor

Shanghai Xianwei Medical Technology Co., Ltd.collaborator

Mapped research locations

ShanghaiShanghai Municipality, China3 JinanShandong, China1 ShenyangLiaoning, China1 ChongqingChongqing Municipality, China1 HarbinHeilongjiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07348211 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.